PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 119 filers reported holding PTC THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $468,846 | -93.2% | 12,600 | -91.2% | 0.00% | -94.3% |
Q4 2019 | $6,917,000 | +187.4% | 144,000 | +102.3% | 0.05% | +178.9% |
Q3 2019 | $2,407,000 | -33.1% | 71,167 | -11.0% | 0.02% | -26.9% |
Q2 2019 | $3,600,000 | +71.8% | 80,000 | +43.7% | 0.03% | +52.9% |
Q1 2019 | $2,095,000 | -10.7% | 55,657 | +11.5% | 0.02% | +13.3% |
Q3 2018 | $2,346,000 | +45.7% | 49,912 | -16.1% | 0.02% | +66.7% |
Q1 2018 | $1,610,000 | +83.8% | 59,523 | +13.4% | 0.01% | +125.0% |
Q4 2017 | $876,000 | +303.7% | 52,500 | +163.8% | 0.00% | +300.0% |
Q4 2016 | $217,000 | -84.5% | 19,900 | -80.1% | 0.00% | -85.7% |
Q3 2016 | $1,401,000 | +230.4% | 100,000 | +663.4% | 0.01% | +250.0% |
Q4 2015 | $424,000 | -91.1% | 13,100 | -92.7% | 0.00% | -92.6% |
Q3 2015 | $4,766,000 | -28.5% | 178,500 | +28.8% | 0.03% | -22.9% |
Q2 2015 | $6,668,000 | +39.3% | 138,541 | +76.2% | 0.04% | +29.6% |
Q1 2015 | $4,786,000 | +168.0% | 78,641 | +127.9% | 0.03% | +145.5% |
Q4 2014 | $1,786,000 | – | 34,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Burrage Capital Management LLC | 160,372 | $7,594,000 | 6.15% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 408,000 | $19,319,000 | 5.11% |
RTW INVESTMENTS, LP | 5,293,966 | $250,669,000 | 3.91% |
GEORGE KAISER FAMILY FOUNDATION | 72,105 | $9,925,000 | 2.07% |
SECTORAL ASSET MANAGEMENT INC | 504,928 | $23,908,000 | 1.81% |
Redwood Investments, LLC | 385,014 | $18,230,000 | 1.60% |
ARMISTICE CAPITAL, LLC | 1,396,000 | $66,101,000 | 1.52% |
Integral Health Asset Management, LLC | 100,100 | $4,740,000 | 1.35% |
Sofinnova Investments, Inc. | 466,840 | $22,105,000 | 1.33% |
Chubb Ltd | 8,180 | $387,000 | 1.10% |